Cited by 157Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryInhalation and Respiratory Drug Delivery

Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro

Open access
Colombo, Mariana, Figueiró, Fabrício, de Fraga Dias, Amanda, Teixeira, Helder Ferreira, Battastini, Ana Maria Oliveira, Koester, Letícia Scherer·2018·International Journal of Pharmaceutics

Abstract

In order to search for new approaches to treat glioma, intranasal administration has been proposed as an alternative route to deliver drugs into the brain. Among the drug alternatives, kaempferol (KPF) has been reported to induce glioma cell death. This study aimed to prepare nanoemulsions containing KPF with and without chitosan to investigate their potential for brain delivery following intranasal administration, and to evaluate their antitumor activity against glioma cells. KPF-loaded nanoemulsion (KPF-NE) and KPF-loaded mucoadhesive nanoemulsion (KPF-MNE) were prepared by high-pressure homogenization technique and were characterized for their globule size, zeta potential, drug content, pH, viscosity, mucoadhesive strength and morphology. KPF from KPF-MNE showed significantly higher permeation across the mucosa in ex vivo diffusion studies. Histopathological examination suggests both nanoemulsions to be safe for the nasal mucosa and able to preserve KPF antioxidant capability. KPF-MNE enhanced significantly the amount of drug into rat's brain following intranasal administration (5- and 4.5-fold higher than free drug and KPF-NE, respectively). In addition, KPF-MNE reduced C6 glioma cell viability through induction of apoptosis to a greater extent than either free KPF or KPF-NE. The mucoadhesive nanoemulsion developed for intranasal administration may be a promising system for delivery to the brain, and KPF-MNE is a candidate for further antiglioma trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2018.03.055

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reduced C6 glioma cell viability through induction of apoptosis was obtained from nanoemulsions containing chitosan to a greater extent than from free drug solution or nanoemulsion without chitosan.

    “A reduced C6 glioma cell viability through induction of apoptosis was obtained from NEs containing chitosan to a greater extent than either free drug solution or NE without chitosan.”

    From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [74]

  • Kaempferol nanoemulsions showed no toxicity towards nasal mucosa, and ex vivo permeation was higher in formulations containing chitosan than in those without.

    “The NEs showed no toxicity towards nasal mucosa, and ex vivo permeation was higher in the formulations containing chitosan in respect to those without.”

    From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [74]

  • The drug concentration in brain tissue after nasal administration of the kaempferol nanoemulsion containing chitosan was significantly higher than with nanoemulsions without chitosan or drug solutions.

    “The drug concentration (ng/g of tissue) in brain tissue after nasal administration of the NE formulation containing chitosan was found to be significantly higher with respect to NEs without chitosan or drug solutions.”

    From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [74]

  • Kaempferol-loaded nanoemulsions showed nanometric globule size, high loading capacity and entrapment efficiency, and preserved the antioxidant potential of kaempferol.

    “Results showed nanometric globule size, high loading capacity and entrapment efficiency, and NEs were able to preserve the antioxidant potential of kaempferol.”

    From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [74]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Colombo, M., Figueiró, F., de Fraga Dias, A., Teixeira, H. F., Battastini, A. M. O., & Koester, L. S.
Affiliations
Universidade Federal do Rio Grande do Sul (BR)
Corresponding author
Koester, Letícia Scherer
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2018-05
Volume
543
Issue
1-2
Pages
214-223
ISSN
0378-5173 (ISSN-L)
OpenAlex
W2794948476
Cited by
157
References
59
Citations by year
2026: 11 · 2025: 16 · 2024: 15 · 2023: 24 · 2022: 26 · 2021: 23 · 2020: 18 · 2019: 20 · 2018: 4
FWCI
7.63
Type
journal article
Language
en
Open access
Locations
  • International Journal of Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • CAPES
  • MEC (902/2009)
  • CNPq (453927/2014-9)
  • INCT (2014 - 465671/2014-4)
  • FAPERGS
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
kaempferol, intranasal drug delivery, glioma, brain drug delivery, chitosan, high-pressure homogenization, nasal mucosa permeation, C6 glioma cells, apoptosis, anticancer activity
MeSH terms
Adhesiveness, Administration, Intranasal, Animals, Antineoplastic Agents, Brain, Brain Neoplasms, Cell Survival, Emulsions, Glioma, Nasal Mucosa, Swine, Rats, Wistar, Kaempferols, Cell Line, Tumor, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review